Roivant Sciences (ROIV) total liabilities

Total liabilities · fiscal 2026
$416.28M

Roivant Sciences (ROIV) had total liabilities of $416.28M at the end of fiscal 2026 (March 31, 2026). That is 66.7% higher than the $249.74M of fiscal 2025. Figures as of 19 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2026
$416.28M
Change on fiscal 2025
+66.7%
Growth, 5 years
−4.6% a year
Highest on record
$782.02Mfiscal 2023
Lowest on record
$249.74Mfiscal 2025
Fiscal years on record
62021–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Roivant Sciences total liabilities, in more detail

Over the five fiscal years to 2026 total liabilities shrank at a compound 4.6% a year. Across the 6 fiscal years on record (2021–2026), the highest was $782.02M in fiscal 2023 and the lowest $249.74M in fiscal 2025.

History · 6 fiscal years

Total liabilities by fiscal year

Roivant Sciences total liabilities, year by year

Roivant Sciences (ROIV) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2026$416.28M 66.7% up
2025$249.74M 67.7% down
2024$773.95M 1.0% down
2023$782.02M 49.3% up
2022$523.70M 0.8% down
2021$527.69M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Roivant Sciences and comparable companies
CompanyTotal liabilitiesFiscal year
Labcorp Holdings LH$9.76B2025
DexCom DXCM$3.59B2025
Koninklijke Philips PHG€15.96B2025
Roivant Sciences ROIV$416.28M2026
West Pharmaceutical Services WST$1.09B2025
Quest Diagnostics DGX$8.94B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ROIV

Roivant Sciences, figure by figure

Roivant Sciences (ROIV) overview: price, valuation and scorecardAll health care companies by market value

Roivant Sciences total liabilities: questions and answers

How large are Roivant Sciences's total liabilities?

Roivant Sciences (ROIV) had total liabilities of $416.28M at the end of fiscal 2026 (March 31, 2026). That is 66.7% higher than the $249.74M of fiscal 2025.

What is the growth rate of Roivant Sciences's total liabilities?

Over the five fiscal years to 2026 total liabilities shrank at a compound 4.6% a year.

What are the highest and lowest total liabilities figures on record for Roivant Sciences?

Across the 6 fiscal years on record (2021–2026), the highest was $782.02M in fiscal 2023 and the lowest $249.74M in fiscal 2025.

How is Roivant Sciences's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Roivant Sciences it is on record here for 6 fiscal years, 2021 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Roivant Sciences (ROIV) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/ROIV/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.